A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)
Clinical trial NCT05865886 · COMPLETED
Trial details
- NCT number
- NCT05865886
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-05
- Primary completion
- 2024-10-07
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.